These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 22065333

  • 21. Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis.
    Sander M, Spies CD, Martiny V, Rosenthal C, Wernecke KD, von Heymann C.
    Crit Care; 2010; 14(4):R148. PubMed ID: 20682059
    [Abstract] [Full Text] [Related]

  • 22. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
    Dryden PJ, O'Connor JP, Jamieson WR, Reid I, Ansley D, Sadeghi H, Burr LH, Munro AI, Merrick PM.
    Can J Anaesth; 1997 Sep; 44(9):934-41. PubMed ID: 9305556
    [Abstract] [Full Text] [Related]

  • 23. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, Cossolini M, Torri G, Calori G, Benussi S, Alfieri O.
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [Abstract] [Full Text] [Related]

  • 24. Predictors of prolonged mechanical ventilation in a cohort of 5123 cardiac surgical patients.
    Cislaghi F, Condemi AM, Corona A.
    Eur J Anaesthesiol; 2009 May; 26(5):396-403. PubMed ID: 19276979
    [Abstract] [Full Text] [Related]

  • 25. Low-Dose Versus High-Dose Tranexamic Acid Reduces the Risk of Nonischemic Seizures After Cardiac Surgery With Cardiopulmonary Bypass.
    Couture P, Lebon JS, Laliberté É, Desjardins G, Chamberland MÈ, Ayoub C, Rochon A, Cogan J, Denault A, Deschamps A.
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1611-1617. PubMed ID: 28803773
    [Abstract] [Full Text] [Related]

  • 26. Cumulative corticosteroid exposure and infection risk after complex pediatric cardiac surgery.
    Mastropietro CW, Barrett R, Davalos MC, Zidan M, Valentine KM, Delius RE, Walters HL.
    Ann Thorac Surg; 2013 Jun; 95(6):2133-9. PubMed ID: 23602063
    [Abstract] [Full Text] [Related]

  • 27. Characterization of intensive care unit acquired hyponatremia and hypernatremia following cardiac surgery.
    Stelfox HT, Ahmed SB, Zygun D, Khandwala F, Laupland K.
    Can J Anaesth; 2010 Jul; 57(7):650-8. PubMed ID: 20405264
    [Abstract] [Full Text] [Related]

  • 28. Predictors and outcome of ICU readmission after cardiac surgery.
    Litmathe J, Kurt M, Feindt P, Gams E, Boeken U.
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):391-4. PubMed ID: 19795324
    [Abstract] [Full Text] [Related]

  • 29. Risk factors affecting adverse outcomes of cardiac surgery in patients aged 70 years and older.
    Yin YC, Peng SK, Huang JH, Hsieh CH, Tsai TC, Shih YR, Peng SY.
    Acta Anaesthesiol Taiwan; 2007 Dec; 45(4):197-204. PubMed ID: 18251239
    [Abstract] [Full Text] [Related]

  • 30. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R, BART Investigators.
    N Engl J Med; 2008 May 29; 358(22):2319-31. PubMed ID: 18480196
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Topical and low-dose intravenous tranexamic acid in cyanotic cardiac surgery.
    Patel J, Prajapati M, Patel H, Gandhi H, Deodhar S, Pandya H.
    Asian Cardiovasc Thorac Ann; 2017 Feb 29; 25(2):118-122. PubMed ID: 28068786
    [Abstract] [Full Text] [Related]

  • 33. Risk factors associated with readmission after pediatric cardiothoracic surgery.
    Kogon B, Jain A, Oster M, Woodall K, Kanter K, Kirshbom P.
    Ann Thorac Surg; 2012 Sep 29; 94(3):865-73. PubMed ID: 22682942
    [Abstract] [Full Text] [Related]

  • 34. Effect of topical tranexamic acid in open heart surgery.
    Abul-Azm A, Abdullah KM.
    Eur J Anaesthesiol; 2006 May 29; 23(5):380-4. PubMed ID: 16438759
    [Abstract] [Full Text] [Related]

  • 35. Predictors of major postoperative cardiac complications in a surgical ICU.
    Maia PC, Abelha FJ.
    Rev Port Cardiol; 2008 Mar 29; 27(3):321-8. PubMed ID: 18551918
    [Abstract] [Full Text] [Related]

  • 36. [Haemorrhage and morbidity associated with the use of tranexamic acid in cardiac surgery: a retrospective, multicentre cohort study].
    Peña JJ, Mateo E, Martín E, Llagunes J, Carmona P, Blasco L, en representación del Grupo de trabajo de Anestesiología y Cuidados Críticos de Cirugía Cardiaca en la Comunidad Valenciana.
    Rev Esp Anestesiol Reanim; 2013 Mar 29; 60(3):142-8. PubMed ID: 22795924
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A randomized prospective analysis of alteration of hemostatic function in patients receiving tranexamic acid and hydroxyethyl starch (130/0.4) undergoing off pump coronary artery bypass surgery.
    Chakravarthy M, Muniraj G, Patil S, Suryaprakash S, Mitra S, Shivalingappa B.
    Ann Card Anaesth; 2012 Mar 29; 15(2):105-10. PubMed ID: 22508200
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z, Shopen Y, Alon H, Cohen O, Nir RR, Adler Z, Bolotin G.
    J Thorac Cardiovasc Surg; 2013 Jan 29; 145(1):243-8. PubMed ID: 23072702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.